Cocrystal Pharma Inc. (COCP) Financial Statements (2024 and earlier)

Company Profile

Business Address 19805 N. CREEK PARKWAY
BOTHELL, WA 98011
State of Incorp. DE
Fiscal Year End December 31
Industry (SIC) 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete Financial Analysis Financial Benchmarking

Balance Sheet (Statement of Financial Position) ($ in thousands)

6/30/2024
MRQ
12/31/2023
12/31/2022
12/31/2021
12/31/2020
12/31/2019
12/31/2018
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments26,35337,21958,70533,0107,4182,723
Cash and cash equivalents26,35337,21958,70533,0107,4182,723
Restricted cash and investments757550505029
Receivables890716 556644 
Other undisclosed current assets1,7732,168568399169191
Total current assets:29,09140,17859,32334,0158,2812,943
Noncurrent Assets
Operating lease, right-of-use asset1,851274478498677
Property, plant and equipment271342453591431384
Intangible assets, net (including goodwill)   19,09219,09219,09265,195
Goodwill   19,09219,09219,09265,195
Deposits noncurrent assets4646464650 
Other undisclosed noncurrent assets      40
Total noncurrent assets:2,16866220,06920,22720,25065,619
TOTAL ASSETS:31,25940,84079,39254,24228,53168,562
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities3,0229761,2971,0801,9991,077
Employee-related liabilities1041268378
Accounts payable1,2226145786571,511616
Accrued liabilities1,800362615297405383
Debt  72739280214
Deferred rent credit      3
Derivative instruments and hedges, liabilities   12617263
Other undisclosed current liabilities240233209178  
Total current liabilities:3,2621,2161,5451,3582,2861,557
Noncurrent Liabilities
Long-term debt and lease obligation   298379537117
Capital lease obligations117
Finance lease, liability   73414
Liabilities, other than long-term debt1,61357    
Operating lease, liability1,61357291345523
Other undisclosed noncurrent liabilities   (291)(345)  
Total noncurrent liabilities:1,61357298379537117
Total liabilities:4,8751,2731,8431,7372,8231,674
Equity
Equity, attributable to parent26,38439,56777,54952,50525,70866,888
Common stock10898713630
Additional paid in capital342,288337,489336,544297,342260,932253,949
Accumulated deficit(315,914)(297,930)(259,093)(244,908)(235,260)(187,091)
Total equity:26,38439,56777,54952,50525,70866,888
TOTAL LIABILITIES AND EQUITY:31,25940,84079,39254,24228,53168,562

Income Statement (P&L) ($ in thousands)

6/30/2024
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
12/31/2019
12/31/2018
Revenues    2,0146,564 
Gross profit:    2,0146,564 
Operating expenses(18,559)(38,829)(14,221)(11,600)(54,970)(62,924)
Operating loss:(18,559)(38,829)(14,221)(9,586)(48,406)(62,924)
Nonoperating income (expense)575(8)36(62)237294
Loss, foreign currency transaction, before tax(65)(18)(9)   
Interest and debt expense640(2)(4)(8) (58)
Other undisclosed income from continuing operations before equity method investments, income taxes    8 58
Loss from continuing operations before income taxes:(17,344)(38,839)(14,189)(9,648)(48,169)(62,630)
Income tax benefit      13,582
Loss from continuing operations:(17,344)(38,839)(14,189)(9,648)(48,169)(49,048)
Loss before gain (loss) on sale of properties:(14,189)(9,648)(48,169)(49,048)
Net loss:(17,344)(38,839)(14,189)(9,648)(48,169)(49,048)
Other undisclosed net income (loss) attributable to parent(640)24   
Net loss available to common stockholders, diluted:(17,984)(38,837)(14,185)(9,648)(48,169)(49,048)

Comprehensive Income ($ in thousands)

6/30/2024
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
12/31/2019
12/31/2018
Net loss:(17,344)(38,839)(14,189)(9,648)(48,169)(49,048)
Comprehensive loss, net of tax, attributable to parent:(17,344)(38,839)(14,189)(9,648)(48,169)(49,048)

Statements Sources

The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: